Vesugen
Also known as KED, Lys-Glu-Asp, Vascular bioregulator peptide
A short bioregulator peptide discussed in vascular aging and endothelial-function research traditions, usually represented by the tripeptide Lys-Glu-Asp.
Overview
Vesugen is a short bioregulator peptide usually represented as Lys-Glu-Asp or KED. It is discussed around vascular aging, endothelial function, and microcirculation.
The Science
The research premise is tissue-specific regulation rather than a classic receptor-drug model.
- Endothelial biology - blood-vessel lining function and stress response.
- Vascular aging - microcirculation and vessel resilience claims.
- Bioregulator category - evidence often comes from regional or preclinical literature.
Evidence Snapshot
Vesugen has limited high-quality human evidence. It should be framed as a research peptide and product-literacy topic, not as a proven vascular medicine.
Related
More in Longevity
5-Amino-1MQ
Research compoundLongevity
Not a peptideSmall molecule
A small-molecule compound that researchers and self-experimenters study for its effects on metabolism, body composition, cellular energy, and healthy aging. Often discussed as a tool for understanding and potentially optimizing metabolic flexibility through NNMT inhibition.
B12
FDA-approvedLongevity
Not a peptideVitamin
An essential water-soluble vitamin required for red blood cell formation, nervous-system function, DNA synthesis, and one-carbon metabolism; it is not a peptide.
Cardiogen
Research compoundLongevity
A short bioregulator peptide discussed in cardiovascular-aging research traditions, usually represented by the tetrapeptide Ala-Glu-Asp-Arg.